633 related articles for article (PubMed ID: 19550318)
1. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
Zikria JC; Ansell J
Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
[TBL] [Abstract][Full Text] [Related]
2. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
[TBL] [Abstract][Full Text] [Related]
3. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
Steffel J; Lüscher TF
J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
[TBL] [Abstract][Full Text] [Related]
4. Direct Factor Xa and direct thrombin inhibitors: a clinical trial update.
Turpie AG
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):497-508. PubMed ID: 19562646
[TBL] [Abstract][Full Text] [Related]
5. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.
Mavrakanas T; Bounameaux H
Pharmacol Ther; 2011 Apr; 130(1):46-58. PubMed ID: 21185864
[TBL] [Abstract][Full Text] [Related]
6. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
Morell J; Sullivan B; Khalabuda M; McBride BF
J Clin Pharmacol; 2010 Sep; 50(9):986-1000. PubMed ID: 20124518
[TBL] [Abstract][Full Text] [Related]
7. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
Andersen JC
Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
[TBL] [Abstract][Full Text] [Related]
8. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
Merli G; Spyropoulos AC; Caprini JA
Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
[TBL] [Abstract][Full Text] [Related]
9. Novel oral anticoagulants.
Khoo CW; Tay KH; Shantsila E; Lip GY
Int J Clin Pract; 2009 Apr; 63(4):630-41. PubMed ID: 19222611
[TBL] [Abstract][Full Text] [Related]
10. Long-term anticoagulation: the prospects for alternatives to warfarin.
Ansell J
Semin Vasc Surg; 2005 Sep; 18(3):134-8. PubMed ID: 16168888
[TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
Zikria J; Ansell J
Discov Med; 2009 Dec; 8(43):196-203. PubMed ID: 20040270
[TBL] [Abstract][Full Text] [Related]
12. Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.
Ahrens I; Peter K; Lip GY; Bode C
Discov Med; 2012 Jun; 13(73):433-43. PubMed ID: 22742649
[TBL] [Abstract][Full Text] [Related]
13. Old and new anticoagulant drugs: a minireview.
Mannucci PM; Franchini M
Ann Med; 2011 Mar; 43(2):116-23. PubMed ID: 21254900
[TBL] [Abstract][Full Text] [Related]
14. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
15. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
Martí-Fàbregas J; Mateo J
Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
[TBL] [Abstract][Full Text] [Related]
16. New anticoagulants.
Bauer KA
Curr Opin Hematol; 2008 Sep; 15(5):509-15. PubMed ID: 18695376
[TBL] [Abstract][Full Text] [Related]
17. New oral anticoagulants in atrial fibrillation.
Turpie AG
Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
[TBL] [Abstract][Full Text] [Related]
18. Oral factor Xa inhibitors for venous thromboembolism prevention in major orthopedic surgery: a review.
Imberti D; Prisco D
Pathophysiol Haemost Thromb; 2008; 36(5):217-26. PubMed ID: 19996630
[TBL] [Abstract][Full Text] [Related]
19. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
20. [Rivaroxaban: mode of action].
Drouet L
Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S9-15. PubMed ID: 19185786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]